Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
In one specific embodiment of the auris-acceptable controlled-release formulations described herein, the active agent is provided in a gel matrix, also referred to herein as auris-acceptable gel formulations, auris interna-acceptable gel formulations, auris media-acceptable gel formulations, auris externa-acceptable gel formulations, auris gel formulations, or variations thereof
Mitochondria and inflammatory bowel diseases: toward a stratified therapeutic intervention
Risk of Fetal Malformations During Dosage Initiation or Escalation in Pregnancy XENPOZYME dosage initiation or escalation, at any time during pregnancy, is not recommended as it may lead to elevated sphingomyelin metabolite levels that may increase the risk of fetal malformations
Inflammation plays a key role in the etiology of BPH through multiple pathways involving the stimulation of proliferation by cytokines and growth factors, as well as the induction of EMT
US$ 20.10
US$ 27.88
US$ 21.87
US$ 25.35
US$ 20.74
US$ 22.95
US$ 24.13